Blood test showed promise for early detection of acute heart transplant rejection
On Jan. 13, 2021, researchers announced they had developed a blood test that could make it possible for…
NIAID scientists studied salmonella swimming behavior as clues to infection
On Jan. 13, 2021, National Institutes of Health scientists and their colleagues announced they had identified a S….
Oxford Immunotec’s T-SPOT SARS-CoV-2 test used to measure efficacy of Valneva’s COVID-19 vaccine candidate
On Jan. 13, 2021, Oxford Immunotec announced the start of a collaboration with Valneva whereby it will perform…
Mateon announced positive interim results from its ARTI-19 clinical trial evaluating ARTIVeda against COVID-19
On Jan. 13, 2021, Mateon Therapeutics reported positive interim results from its ARTI-19 clinical trial evaluating ARTIVedaTM against…
Tests at an Oregon mink farm showed SARS-CoV-2 still present with no virus mutations
On Jan. 13, 2021, the Oregon Department of Agriculture (ODA) continueed to test, survey, and trap at an…
Biotechnology | Diagnostics | Disease | Life Science News | Non-Profit Research | Therapeutics | Women's Health
Rising protocol design complexity reported driving rapid growth in clinical trial data volume
On Jan. 12, 2021, the Tufts Center for the Study of Drug Development reported that ever more complex…
Swissmedic authorized COVID-19 vaccine Moderna for Use in Switzerland
On Jan. 12, 2021, Moderna announced that Swissmedic, the Swiss Agency for Therapeutic Products, had authorized the COVID-19…
UTSW researchers identified new gene involved in breast cancer growth
On Jan. 12, 2021, a team researchers from the University of Texas Southwestern (UTSW) announced they had identified…
FDA cleared initiation of the Editas Medicine’s EDIT-301 clinical trial using CRISPR/Cas12a gene editing
On Jan. 11, 2021, Editas Medicine announced the U.S. Food and Drug Administration (FDA) had cleared the initiation…
Baxter Biopharma Solutions announced sterile manufacturing agreement for Novavax COVID-19 vaccine
On Jan. 11, 2021, Baxter announced an agreement to provide sterile manufacturing services for NVX-CoV2373, Novavax COVID-19 recombinant…
T2 Biosystems T2SARS-CoV-2 panel proved effective with global rise in variants of the SARS-CoV-2 virus
On Jan. 11, 2021, T2 Biosystems announced that its T2SARS-CoV-2 Panel – a molecular diagnostic test that detects…
Biotechnology | COVID-19 | HIV | Influenza | Life Science News | Vaccine
Moderna announced three new development programs in infectious disease vaccines
On Jan. 11, 2021, Moderna announced that it was expanding its pipeline of innovative vaccines with three new…
AXIM released manuscript describing rapid point-of-care test that measures COVID-19 neutralizing antibodies
On Jan. 11, 2021, AXIM Biotechnologies announced that it had released a preprint of its manuscript describing the…
American Cancer Society reported largest one-year drop in cancer mortality from 1991-2017
On Jan. 8, 2021, the American Cancer Society reported that the death rate from cancer in the U.S….
UK medicines regulator approved Moderna vaccine as third COVID-19 vaccine
On Jan. 8, 2021, the COVID-19 vaccine developed by Moderna has today been given regulatory approval for supply…
UK Medicines and Healthcare products regulatory agency authorized use of COVID-19 Vaccine Moderna
On Jan. 8, 2021, the Medicines and Healthcare products Regulatory Agency (MHRA) announced it had accepted the recommendation…
BioNTech confirmed EC’s proposal to purchase additional doses of vaccine
On Jan. 8, 2021, BioNTech announced that it was in talks with the European Commission (EC) about an…
Novavax finalized agreement with Commonwealth of Australia for 51 million doses of COVID-19 vaccine
On Jan. 7, 2021, Novavax announced that it had executed an Advance Purchase Agreement with the Commonwealth of…
Protective immunity against SARS-CoV-2 could last eight months or more
On Jan. 6, 2021, the La Jolla Institute for Immunology announced data that suggest nearly all COVID-19 survivors…
European Commission authorized COVID-19 vaccine Moderna in Europe
On Jan. 6, 2021, Moderna announced that the European Commission had granted a conditional marketing authorization for COVID-19…
Illumina and Helix collaborated to assess prevalence of New SARS-CoV-2 UK variant (B117) in the U.S.
On Jan. 5, 2021, Illumina and Helix announced a collaboration to augment national surveillance infrastructure in the U.S….
First evidence of UK coronavirus variant in California confirmed by Scripps Research lab
On Jan. 4, 2021, a research partnership between scientists at Scripps Research and UC San Diego found the…
Moderna provided COVID-19 vaccine supply update
On Jan. 4, 2021, Moderna announced a supply update for the Moderna COVID-19 Vaccine, increasing its base-case global…
Israeli Ministry of Health authorized COVID-19 Vaccine Moderna
On Jan. 4, 2021, Moderna announced that Israel’s Ministry of Health (MOH) had given authorization to import the…
INOVIO and Advaccine announced partnership to commercialize COVID-19 DNA vaccine candidate in China
On Jan. 4, 2021, Inovio Pharmaceuticals and Advaccine Biopharmaceuticals announced that they had entered into a collaboration and…
Biotechnology | COVID-19 | Life Science News | Vaccine | WHO
WHO issued its first EUV for a COVID-19 vaccine and emphasized need for equitable global access
On Dec. 31, 2020, the World Health Organization (WHO) listed the Comirnaty COVID-19 mRNA vaccine for emergency use,…
Moderna confirmed 40 million COVID-19 vaccine dose supply agreement with Republic of Korea
On Dec. 31, 2020, Moderna confirmed it had entered into a supply agreement with the government of the…
CytoDyn research on critically Ill COVID-19 patients published in Journal of Translational Autoimmunity
On Dec. 31, 2020, CytoDyn announced a research manuscript submitted by Nicholas J. Agresti, M.D. had been accepted…
Recipharm and Moderna finalized agreement for aseptic drug manufacturing and fill-finish for countries outside the U.S.
On Dec. 30, 2020, Moderna announced that they had reached an agreement to support formulation and fill-finish a…
Peer-reviewed report on Moderna COVID-19 vaccine published
On Dec. 30, 2020, the National Institutes of Health (NIH) announced that the investigational vaccine known as mRNA-1273…